Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiner

Showing results (71-80 of 145) with videos related to

Pageof 15
Sort By:
Scientific Reports|July 9, 2020
Fluorescence-guided resection of tumors in mouse models of oral cancerPaula Demétrio de Souza França, Navjot Guru, Sheryl Roberts, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2017
Targeted PET imaging strategy to differentiate malignant from inflamed lymph nodes in diffuse large B-cell lymphomaJun Tang, Darin Salloum, Brandon Carney, et al.
Dalton Transactions (Cambridge, England : 2003)|May 25, 2019
Novel latonduine derived proligands and their copper(ii) complexes show cytotoxicity in the nanomolar range in human colon adenocarcinoma cells and in vitro cancer selectivityFelix Bacher, Christopher Wittmann, Márta Nové, et al.
Bioconjugate Chemistry|July 1, 2016
Pretargeted PET Imaging Using a Site-Specifically Labeled ImmunoconjugateBrendon E Cook, Pierre Adumeau, Rosemery Membreno, et al.
Bioconjugate Chemistry|May 27, 2014
In vivo imaging of GLP-1R with a targeted bimodal PET/fluorescence imaging agentChristian Brand, Dalya Abdel-Atti, Yachao Zhang, et al.
EJNMMI Research|July 6, 2018
Discriminating radiation injury from recurrent tumor with [<sup>18</sup>F]PARPi and amino acid PET in mouse modelsPatrick L Donabedian, Susanne Kossatz, John A Engelbach, et al.
Dalton Transactions (Cambridge, England : 2003)|August 30, 2017
cis-Tetrachlorido-bis(indazole)osmium(iv) and its osmium(iii) analogues: paving the way towards the cis-isomer of the ruthenium anticancer drugs KP1019 and/or NKP1339Gabriel E Büchel, Susanne Kossatz, Ahmad Sadique, et al.
EJNMMI Research|August 30, 2018
Leveraging PET to image folate receptor α therapy of an antibody-drug conjugateChristian Brand, Ahmad Sadique, Jacob L Houghton, et al.
Nature Protocols|July 8, 2017
Measurement of drug-target engagement in live cells by two-photon fluorescence anisotropy imagingClaudio Vinegoni, Paolo Fumene Feruglio, Christian Brand, et al.
Bioconjugate Chemistry|November 5, 2013
(18)F-labeled-bioorthogonal liposomes for in vivo targetingFabien Emmetiere, Christopher Irwin, Nerissa Therese Viola-Villegas, et al.
Pageof 15

Showing results (71-80 of 145) with videos related to

Sort By:
Pageof 15
Scientific Reports|July 9, 2020
Fluorescence-guided resection of tumors in mouse models of oral cancerPaula Demétrio de Souza França, Navjot Guru, Sheryl Roberts, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2017
Targeted PET imaging strategy to differentiate malignant from inflamed lymph nodes in diffuse large B-cell lymphomaJun Tang, Darin Salloum, Brandon Carney, et al.
Dalton Transactions (Cambridge, England : 2003)|May 25, 2019
Novel latonduine derived proligands and their copper(ii) complexes show cytotoxicity in the nanomolar range in human colon adenocarcinoma cells and in vitro cancer selectivityFelix Bacher, Christopher Wittmann, Márta Nové, et al.
Bioconjugate Chemistry|July 1, 2016
Pretargeted PET Imaging Using a Site-Specifically Labeled ImmunoconjugateBrendon E Cook, Pierre Adumeau, Rosemery Membreno, et al.
Bioconjugate Chemistry|May 27, 2014
In vivo imaging of GLP-1R with a targeted bimodal PET/fluorescence imaging agentChristian Brand, Dalya Abdel-Atti, Yachao Zhang, et al.
EJNMMI Research|July 6, 2018
Discriminating radiation injury from recurrent tumor with [<sup>18</sup>F]PARPi and amino acid PET in mouse modelsPatrick L Donabedian, Susanne Kossatz, John A Engelbach, et al.
Dalton Transactions (Cambridge, England : 2003)|August 30, 2017
cis-Tetrachlorido-bis(indazole)osmium(iv) and its osmium(iii) analogues: paving the way towards the cis-isomer of the ruthenium anticancer drugs KP1019 and/or NKP1339Gabriel E Büchel, Susanne Kossatz, Ahmad Sadique, et al.
EJNMMI Research|August 30, 2018
Leveraging PET to image folate receptor α therapy of an antibody-drug conjugateChristian Brand, Ahmad Sadique, Jacob L Houghton, et al.
Nature Protocols|July 8, 2017
Measurement of drug-target engagement in live cells by two-photon fluorescence anisotropy imagingClaudio Vinegoni, Paolo Fumene Feruglio, Christian Brand, et al.
Bioconjugate Chemistry|November 5, 2013
(18)F-labeled-bioorthogonal liposomes for in vivo targetingFabien Emmetiere, Christopher Irwin, Nerissa Therese Viola-Villegas, et al.
Pageof 15